Caputo, V.; Libera, M.; Campos Mota, Y.; Nagashima, K.; Moreno Martin, A.M.; Trombetta, C.M.; Dapporto, F.; Mousa, J.J.; Montomoli, E.; Sautto, G.A.;
et al. Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies. Vaccines 2026, 14, 71.
https://doi.org/10.3390/vaccines14010071
AMA Style
Caputo V, Libera M, Campos Mota Y, Nagashima K, Moreno Martin AM, Trombetta CM, Dapporto F, Mousa JJ, Montomoli E, Sautto GA,
et al. Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies. Vaccines. 2026; 14(1):71.
https://doi.org/10.3390/vaccines14010071
Chicago/Turabian Style
Caputo, Valeria, Martina Libera, Yailin Campos Mota, Kaito Nagashima, Ana Maria Moreno Martin, Claudia Maria Trombetta, Francesca Dapporto, Jarrod J. Mousa, Emanuele Montomoli, Giuseppe A. Sautto,
and et al. 2026. "Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies" Vaccines 14, no. 1: 71.
https://doi.org/10.3390/vaccines14010071
APA Style
Caputo, V., Libera, M., Campos Mota, Y., Nagashima, K., Moreno Martin, A. M., Trombetta, C. M., Dapporto, F., Mousa, J. J., Montomoli, E., Sautto, G. A., & Diotti, R. A.
(2026). Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies. Vaccines, 14(1), 71.
https://doi.org/10.3390/vaccines14010071
